Related Experiment Video
Updated: Aug 12, 2026
06:11
Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
Published on: May 17, 2024
Blood Glucose Monitoring in the Neonatal Period: A Study on Evaluation Using the RAPIDPoint 500/500e
Izumi Kurosawa1, Hiroshi Miyabayashi1,2, Yasue Goko1
1Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Summary
Bedside blood gas analyzers offer reliable glucose measurements in neonatal intensive care units. However, confirm results with lab testing when severe hypoglycemia is suspected due to potential discrepancies.
Area of Science:
- Neonatal medicine
- Clinical chemistry
- Medical technology
Background:
- Accurate glucose monitoring is critical in neonatal intensive care units (NICUs) for prompt hypoglycemia detection.
- Evaluating the concordance between bedside blood gas analyzers (GasBS) and central laboratory (LabBS) glucose measurements is essential.
- Identifying factors contributing to significant glucose measurement discrepancies is crucial for clinical practice.
Purpose of the Study:
- To assess the agreement between neonatal blood glucose levels measured by GasBS and LabBS.
- To identify clinical and physiological factors associated with significant discrepancies in glucose measurements.
- To evaluate the diagnostic performance of GasBS in detecting neonatal hypoglycemia.
Main Methods:
- Retrospective analysis of 5436 paired glucose specimens from 2105 NICU infants.
- Bland-Altman analysis, correlation, and linear mixed models for agreement assessment.
- Generalized linear mixed models and ROC analysis to evaluate discrepancies and detection performance.
Main Results:
- GasBS and LabBS demonstrated good agreement (mean difference 1.88 mg/dL, correlation ρ=0.939).
- Lower base excess, lower oxygenated hemoglobin, higher postnatal age, and higher hematocrit were associated with discrepancies.
- GasBS showed high accuracy in detecting hypoglycemia (LabBS < 40 mg/dL), with an AUC of 0.985.
Conclusions:
- Bedside blood gas analyzers provide clinically valuable glucose measurements for newborns.
- Physiological factors can influence glucose measurement discrepancies, necessitating careful interpretation.
- Confirmatory laboratory testing is vital when severe neonatal hypoglycemia is suspected.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...